Switching to extended half‐life products in Canada – preliminary data Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 2017
has subject area
- 1103 Clinical Sciences (FoR)
- Canada (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Approval (MeSH)
- Factor IX (MeSH)
- Factor VIII (MeSH)
- Half-Life (MeSH)
- Hemophilia A (MeSH)
- Humans (MeSH)
- Immunoglobulin Fc Fragments (MeSH)
- Recombinant Fusion Proteins (MeSH)
published in
- Haemophilia Journal